NRIX
Common StockNurix Therapeutics, Inc.
Reported Shares
7.9M
Position Mix
No options reported
Reported Value
$187.3M
Portfolio Weight
13.71%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$1.4B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
NRIX
Common StockNurix Therapeutics, Inc.
Reported Shares
7.9M
Position Mix
No options reported
Reported Value
$187.3M
Portfolio Weight
13.71%
KRYS
Common StockKrystal Biotech, Inc.
Reported Shares
527.7K
Position Mix
No options reported
Reported Value
$175.5M
Portfolio Weight
12.84%
SRRK
Common StockScholar Rock Holding Corp
Reported Shares
3M
Position Mix
No options reported
Reported Value
$146.6M
Portfolio Weight
10.73%
STOK
Common StockStoke Therapeutics, Inc.
Reported Shares
3.9M
Position Mix
No options reported
Reported Value
$100.6M
Portfolio Weight
7.36%
IMNM
Common StockImmunome Inc.
Reported Shares
4.4M
Position Mix
No options reported
Reported Value
$93.8M
Portfolio Weight
6.87%
ABSI
Common StockAbsci Corp
Reported Shares
6.7M
Position Mix
No options reported
Reported Value
$71.9M
Portfolio Weight
5.26%
ETRA
Common StockElectra Therapeutics, Inc.
Reported Shares
5.4M
Position Mix
No options reported
Reported Value
$61.1M
Portfolio Weight
4.47%
ANNX
Common StockAnnexon, Inc.
Reported Shares
14.3M
Position Mix
No options reported
Reported Value
$60.4M
Portfolio Weight
4.42%
NGNE
Common StockNeurogene Inc.
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$43.5M
Portfolio Weight
3.18%
RGNX
Common StockREGENXBIO Inc.
Reported Shares
5M
Position Mix
No options reported
Reported Value
$38.0M
Portfolio Weight
2.78%
STTK
Common StockShattuck Labs, Inc.
Reported Shares
5.1M
Position Mix
No options reported
Reported Value
$34.7M
Portfolio Weight
2.54%
FATE
Common StockFATE THERAPEUTICS INC
Reported Shares
12.9M
Position Mix
No options reported
Reported Value
$30.5M
Portfolio Weight
2.23%
SLN
Depositary ReceiptSilence Therapeutics plc
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$26.9M
Portfolio Weight
1.97%
BEAM
Common StockBeam Therapeutics Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$26.0M
Portfolio Weight
1.90%
ATTO
Common StockAttovia Therapeutics, Inc.
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$19.9M
Portfolio Weight
1.46%
AGMB
Depositary ReceiptAgomab Therapeutics NV
Reported Shares
1.7M
Position Mix
No options reported
Reported Value
$19.3M
Portfolio Weight
1.41%
NUVB
Common StockNuvation Bio Inc.
Reported Shares
3M
Position Mix
No options reported
Reported Value
$17.0M
Portfolio Weight
1.24%
ADRX
Common StockADARx Pharmaceuticals, Inc.
Reported Shares
769.3K
Position Mix
No options reported
Reported Value
$15.3M
Portfolio Weight
1.12%
IDYA
Common StockIDEAYA Biosciences, Inc.
Reported Shares
381.3K
Position Mix
No options reported
Reported Value
$14.7M
Portfolio Weight
1.07%
ADCT
Common StockADC Therapeutics SA
Reported Shares
11.6M
Position Mix
No options reported
Reported Value
$14.1M
Portfolio Weight
1.03%